Shanghai Putite Composite Materials Co., Ltd. 2025 Annual Report of Independent Director
To all shareholders and shareholder representatives:
As an independent director of Shanghai Putite Composite Materials Co., Ltd. (hereinafter referred to as the "Company"), in accordance with the "Company Law," "Securities Law," "Administrative Measures for Independent Directors of Listed Companies," "Normative Operation Guidelines for Listed Companies of Shenzhen Stock Exchange," and the Company's "Independent Director System" and "Articles of Association," and other relevant laws, regulations, and rules, I have faithfully and diligently performed my duties during my term of office in 2025. I have actively undertaken all responsibilities of an independent director, conscientiously reviewed all proposals from the Independent Director Special Committee, relevant special committees of the Board of Directors, and the Board of Directors, fully exercised my professional independence, strived to safeguard the overall interests of the Company and the legitimate rights and interests of all shareholders, especially small and medium shareholders, and promoted the standardized operation of the Company.
In September 2025, due to the election of a new board of directors for the Company, I was appointed as an independent director. I hereby report on the performance of my duties as an independent director during my term of office in 2025:
I. Basic Information of Independent Director
During the reporting period, I served as an independent director of the seventh session of the Board of Directors of the Company, possessing relevant professional qualifications and capabilities, and having accumulated rich experience in my professional field.
(I) Personal Work Experience, Professional Background, and Concurrent Positions
Tang Yunwei, male, formerly worked at Shanghai University of Finance and Economics, holding positions such as lecturer, associate professor, assistant to the president, professor, and vice president. He was also honored as an honorary member of the Chartered Association of Accountants (UK), a distinguished international visiting professor of the American Accounting Association, and an honorary fellow of Lingnan University, Hong Kong. He has served as a member of the Chinese Accounting Standards Committee, a member of the Auditing Standards Committee of the Ministry of Finance of China, president of the Shanghai Institute of Accounting, and a member of the listing committee of the Shanghai Stock Exchange. He holds a Ph.D. in Accounting from Shanghai University of Finance and Economics and is a founder of the Chinese Accounting Professors Association. He is an independent director of Ping An Good Doctor and an independent director of Shanghai Putite Composite Materials Co., Ltd.
(II) Statement on Independence
During the reporting period, my tenure as an independent director of the Company complied with the requirements of independence stipulated in the "Administrative Measures for Independent Directors of Listed Companies" and other laws and regulations, and there were no circumstances that affected my independent performance of duties.
II. Overview of Independent Director's Performance in 2025
(I) Attendance at Meetings
- Attendance at Board and Shareholder Meetings
In 2025, the Company held thirteen board meetings and five shareholder meetings, all of which were conducted through on-site and telecommunication methods. During the reporting period, my attendance was as follows:
| Item | Number of Board Meetings Attended | Number of Board Meetings Personally Attended | Number of Board Meetings Attended by Proxy | Number of Board Meetings Attended by Communication | Number of Board Meetings Absent | Whether Personally Attended Meetings for Two Consecutive Years | Number of Shareholder Meetings Attended | Whether Attended Shareholder Meetings |
|---|---|---|---|---|---|---|---|---|
| 2025 | 5 | 2 | 3 | 0 | 0 | No | 2 | Yes |
In 2025, I strictly complied with relevant regulations to attend meetings. Based on a thorough understanding of the proposals, I exercised my voting rights prudently and independently. During the reporting period, I voted in favor of all proposals submitted to the Company's board of directors and did not raise any objections. There were no abstentions, dissenting votes, or instances where I was unable to express an opinion.